WallStreetZenWallStreetZen

NASDAQ: DMAC
Diamedica Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for DMAC

Based on 2 analysts offering 12 month price targets for Diamedica Therapeutics Inc.
Min Forecast
$6.00+139.04%
Avg Forecast
$7.00+178.88%
Max Forecast
$8.00+218.73%

Should I buy or sell DMAC stock?

Based on 2 analysts offering ratings for Diamedica Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DMAC stock forecasts and price targets.

DMAC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-21

1 of 1

DMAC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DMAC$2.51$7.00+178.88%Buy
IOBT$1.44$8.00+455.56%Buy
ANIX$3.01$12.00+298.67%Buy
ORMP$2.33N/AN/A
MCRB$0.63$4.75+660.00%Hold

Diamedica Therapeutics Stock Forecast FAQ

Is Diamedica Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: DMAC) stock is to Buy DMAC stock.

Out of 2 analysts, 0 (0%) are recommending DMAC as a Strong Buy, 2 (100%) are recommending DMAC as a Buy, 0 (0%) are recommending DMAC as a Hold, 0 (0%) are recommending DMAC as a Sell, and 0 (0%) are recommending DMAC as a Strong Sell.

If you're new to stock investing, here's how to buy Diamedica Therapeutics stock.

What is DMAC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year DMAC price target, the average DMAC price target is $7.00, with the highest DMAC stock price forecast at $8.00 and the lowest DMAC stock price forecast at $6.00.

On average, Wall Street analysts predict that Diamedica Therapeutics's share price could reach $7.00 by Mar 21, 2025. The average Diamedica Therapeutics stock price prediction forecasts a potential upside of 178.88% from the current DMAC share price of $2.51.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.